Streetbeat News

Acquisitions Mergers

EQ

Equillium announced that Ono Pharmaceutical has decided not to exercise its option to acquire rights to itolizumab. Equillium is now considering accelerating the completion of its Phase 3 EQUATOR study in aGVHD to Q1 2025, with Phase 2 ulcerative colitis study topline data expected in the same quarter.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:45 am

ALRN

Aileron Therapeutics has entered an exclusive option agreement with Advancium Health Network for the potential acquisition of ALRN-6924, a drug developed by Aileron. Advancium paid a non-refundable fee for the option and plans to evaluate ALRN-6924 as a treatment for retinoblastoma, a rare eye cancer. If the option is exercised, Aileron could receive additional payments and royalties.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:38 am

AVTE

Aerovate Therapeutics and Jade Biosciences have agreed to merge in an all-stock transaction, creating a company focused on Jade's biologics portfolio, including JADE-001 for IgA Nephropathy. The new entity will trade on Nasdaq under 'JBIO'.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:23 am

ADTX

Appili Therapeutics has announced an agreement with the FDA on the development requirements for its ATI-1801 topical antiparasitic product NDA submission. Additionally, Appili has agreed to be acquired by Aditxt, which will acquire all issued and outstanding shares.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:21 am

AME

AMETEK has acquired Virtek Vision, a Canadian company specializing in laser-based projection and inspection systems. Virtek will become part of AMETEK's Electronic Instruments Group. The financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:15 am

LASE

Laser Photonics has signed a definitive agreement to acquire Control Micro Systems. The terms of the deal have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:11 am

ANIK

Anika Therapeutics has completed the sale of its Arthrosurface business to Phoenix Brio, Incorporated for $10 million, including a $7 million promissory note and up to $3 million based on sales performance. Anika also plans to divest its Parcus Medical business.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:10 am

RPM

RPM International has acquired TMP Convert to integrate it into its Fibergrate Structures business, part of RPM's Performance Coatings Group. TMP Convert, based in France, is a leading manufacturer of outdoor design and landscape products with annual net sales of approximately €35 million. The terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 10:52 am

EPWK

UPWK

EPWK Holdings Inc. has increased its IPO fundraising target by about a third, planning to raise up to $16.5 million by offering 2.75 million shares at a lower price range of $4 to $6. This move comes as U.S.-listed China stocks rally, and EPWK aims to capitalize on the growing gig economy in China. Despite stable revenue, the company faces challenges with negative cash flow and declining gross profit margins.

Portfolio Pulse from The Bamboo Works

October 31, 2024 | 10:24 am

CTRE

CareTrust REIT, Inc. (NYSE:CTRE) has announced an upsized public offering of 13.8 million shares at $32 per share, with the proceeds intended for nursing facility acquisitions. The offering is expected to close on November 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 8:20 am